REPL · Replimune Group, Inc. · Analyst Estimates
$16.12
+3.07 (+23.52%)
At close · Oct 28
Return incl. dividend (before tax)
Earnings today
Q2 2027 earnings call transcript
Going-concern doubt
— cleared Oct 28, 2026
The latest filing states the doubt was alleviated.
“As described in the Company's Annual Report on Form 10-K for the year ended March 31, 2026, substantial doubt existed about the Company's ability to continue as a going concern. The conditions that raised substantial doubt have been subsequently alleviated, as the Company raised approximately $141.0 million in net proceeds from an equity offering in August 2026.”View the 10-Q filed Oct 28, 2026
Market Cap
$1.21B
Shares
94.80M
Volume · Oct 28
3.9M
Avg daily vol (3M)
3.88M
Analyst Estimates
Compare analyst forecasts for Replimune Group, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-04 16:17 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2027-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-3.21
|
-3.01
|
-2.80
|
2
|
-2.98
|
-2.98
|
-1.94
|
-2.09
|
0
|
1
|
0
|
1
|
|
Revenue
USD
Publication date not stated |
3.00M
|
28.87M
|
75.00M
|
6
|
— | — | — | — | — | — | — | — |
FY ending 2028-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-2.48
|
-1.82
|
-1.38
|
3
|
-2.04
|
-2.04
|
-1.15
|
-1.10
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
27.60M
|
172.57M
|
360.00M
|
7
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.82
|
-0.79
|
-0.76
|
2
|
-0.83
|
-0.83
|
-0.56
|
-0.54
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
0.00
|
0.00
|
0.00
|
7
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.83
|
-0.76
|
-0.69
|
2
|
-0.79
|
-0.79
|
-0.44
|
-0.49
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
0.00
|
6.69M
|
20.60M
|
7
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1737953
CUSIP
76029N106
13F (30d)
34 filings
34 filers
Visit website
Investor relations